Gavin Arno1, Sarah Hull1, Anthony G Robson1, Graham E Holder1, Michael E Cheetham2, Andrew R Webster1, Vincent Plagnol3, Anthony T Moore4. 1. UCL Institute of Ophthalmology, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom. 2. UCL Institute of Ophthalmology, London, United Kingdom. 3. University College London Genetics Institute, London, United Kingdom. 4. UCL Institute of Ophthalmology, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom 4Ophthalmology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom 5Department of Ophthalmology, University of Cali.
Abstract
PURPOSE: We present a detailed clinical and molecular study of four patients from two consanguineous families with a similar childhood-onset retinal dystrophy resulting from novel homozygous nonsense mutations in RBP3. METHODS: Four children with mutations in RBP3 encoding interphotoreceptor binding protein (IRBP) were ascertained by whole exome sequencing and subsequent direct Sanger sequencing. Detailed phenotyping was performed, including full clinical evaluation, electroretinography, fundus photography, fundus autofluorescence (FAF) imaging, and spectral-domain optical coherence tomography (OCT). RESULTS: Two novel homozygous nonsense mutations (c.1530T>A;p.Y510* and c.3454G>T;p.E1152*) in RBP3 were identified in four patients from two families. All four patients had a similar, unusual retinal dystrophy characterized by childhood onset high myopia, generalized rod and cone dysfunction, and an unremarkable fundus appearance. The FAF imaging showed multiple paracentral foci of low autofluorescence in one patient and patchy increased FAF in the region of the vascular arcades in another. The OCT showed loss of outer retinal bands over peripheral macular areas in all 4 cases. CONCLUSIONS: To our knowledge, this report is the first to describe the retinal dystrophy in children caused by homozygous nonsense RBP3 mutations, highlighting the requirement for IRBP in normal eye development and visual function. Longitudinal study will reveal if the four children reported here will progress to a more typical retinitis pigmentosa phenotype described previously in adults with RBP3 mutations. The RBP3-related disease should be considered in children with high myopia and retinal dystrophy, particularly when there are no significant fundus changes.
PURPOSE: We present a detailed clinical and molecular study of four patients from two consanguineous families with a similar childhood-onset retinal dystrophy resulting from novel homozygous nonsense mutations in RBP3. METHODS: Four children with mutations in RBP3 encoding interphotoreceptor binding protein (IRBP) were ascertained by whole exome sequencing and subsequent direct Sanger sequencing. Detailed phenotyping was performed, including full clinical evaluation, electroretinography, fundus photography, fundus autofluorescence (FAF) imaging, and spectral-domain optical coherence tomography (OCT). RESULTS: Two novel homozygous nonsense mutations (c.1530T>A;p.Y510* and c.3454G>T;p.E1152*) in RBP3 were identified in four patients from two families. All four patients had a similar, unusual retinal dystrophy characterized by childhood onset high myopia, generalized rod and cone dysfunction, and an unremarkable fundus appearance. The FAF imaging showed multiple paracentral foci of low autofluorescence in one patient and patchy increased FAF in the region of the vascular arcades in another. The OCT showed loss of outer retinal bands over peripheral macular areas in all 4 cases. CONCLUSIONS: To our knowledge, this report is the first to describe the retinal dystrophy in children caused by homozygous nonsense RBP3 mutations, highlighting the requirement for IRBP in normal eye development and visual function. Longitudinal study will reveal if the four children reported here will progress to a more typical retinitis pigmentosa phenotype described previously in adults with RBP3 mutations. The RBP3-related disease should be considered in children with high myopia and retinal dystrophy, particularly when there are no significant fundus changes.
Authors: Yilin Zhao; Phillip A Wilmarth; Catherine Cheng; Saima Limi; Velia M Fowler; Deyou Zheng; Larry L David; Ales Cvekl Journal: Exp Eye Res Date: 2018-10-22 Impact factor: 3.467
Authors: Gavin Arno; Keren J Carss; Sarah Hull; Ceniz Zihni; Anthony G Robson; Alessia Fiorentino; Alison J Hardcastle; Graham E Holder; Michael E Cheetham; Vincent Plagnol; Anthony T Moore; F Lucy Raymond; Karl Matter; Maria S Balda; Andrew R Webster Journal: Am J Hum Genet Date: 2017-01-26 Impact factor: 11.025
Authors: Shanu Markand; Natecia L Baskin; Ranjay Chakraborty; Erica Landis; Sara A Wetzstein; Kevin J Donaldson; Priyanka Priyadarshani; Shannon E Alderson; Curran S Sidhu; Jeffrey H Boatright; P Michael Iuvone; Machelle T Pardue; John M Nickerson Journal: Mol Vis Date: 2016-10-27 Impact factor: 2.367